Citation: T. Vonarnim, PROGNOSTIC-SIGNIFICANCE OF TRANSIENT ISCHEMIC EPISODES - RESPONSE TO TREATMENT SHOWS IMPROVED PROGNOSIS - RESULTS OF THE TOTAL ISCHEMIC BURDEN BISOPROLOL STUDY (TIBBS) FOLLOW-UP, Journal of the American College of Cardiology, 28(1), 1996, pp. 20-24
Citation: T. Vonarnim, MEDICAL-TREATMENT TO REDUCE TOTAL ISCHEMIC BURDEN - TOTAL ISCHEMIC BURDEN BISOPROLOL STUDY (TIBBS), A MULTICENTER TRIAL COMPARING BISOPROLOL AND NIFEDIPINE, Journal of the American College of Cardiology, 25(1), 1995, pp. 231-238
Citation: T. Vonarnim, TOTAL ISCHEMIC BURDEN - BETA-BLOCKADE OR CALCIUM ANTAGONISM - RESULTSOF THE TIBBS TRIAL, Journal of the American College of Cardiology, 1994, pp. 10000053-10000053
Citation: W. Pliml et al., EFFECTS OF THERAPEUTIC RIBOSE LEVELS ON HUMAN LYMPHOCYTE-PROLIFERATION IN-VITRO, The Clinical investigator, 71(10), 1993, pp. 770-773